2016
DOI: 10.18632/oncotarget.10945
|View full text |Cite
|
Sign up to set email alerts
|

Decellularized scaffolds in regenerative medicine

Abstract: Allogeneic organ transplantation remains the ultimate solution for end-stage organ failure. Yet, the clinical application is limited by the shortage of donor organs and the need for lifelong immunosuppression, highlighting the importance of developing effective therapeutic strategies. In the field of regenerative medicine, various regenerative technologies have lately been developed using various biomaterials to address these limitations. Decellularized scaffolds, derived mainly from various non-autologous org… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
51
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 89 publications
(54 citation statements)
references
References 108 publications
1
51
0
Order By: Relevance
“…Consequently, this was selected as the optimized concentration of GO in the scaffold for the NIH 3T3 cell culture to avoid the potential for cytotoxicity. These results are in agreement with previous studies that have demonstrated that both DT constructs and GO are biocompatible and biodegradable …”
Section: Resultssupporting
confidence: 94%
See 1 more Smart Citation
“…Consequently, this was selected as the optimized concentration of GO in the scaffold for the NIH 3T3 cell culture to avoid the potential for cytotoxicity. These results are in agreement with previous studies that have demonstrated that both DT constructs and GO are biocompatible and biodegradable …”
Section: Resultssupporting
confidence: 94%
“…These natural scaffolds can support angiogenesis due to their notable cell affinity and their ability to provide a microenvironment similar to the extracellular matrix . Decellularized constructs have been used for skin transplantations, cosmetic surgery, and for skin defects, and the results have confirmed that they can support skin regeneration after implantation . Decellularized scaffolds can stimulate important biological processes such as re‐epithelialization, granular tissue formation, and neovascularization at the initial stages of implantation.…”
Section: Introductionmentioning
confidence: 99%
“…Cardiac tissue engineering (CTE) aiming at developing three-dimensional myocardium-like scaffolds for therapeutic use by combining cells, synthetic or natural biomaterials, and biomimetic signals is rapidly emerging as the most promising alternative to heart transplant (Vunjak-Novakovic et al, 2010;Massai et al, 2013;Feric and Radisic, 2016;Stoppel et al, 2016;Fujita and Zimmermann, 2017;Weinberger et al, 2017;Madonna et al, 2019). Among biomaterials, decellularized tissues are emerging as the most promising scaffolds for regenerative medicine, due to their potential to provide natural biological cues (Yaling et al, 2016). However, the regenerative capability of the substrate depends not only on its chemical properties, but also on its ability to recapitulate the mechanical behavior of the native tissue, providing physical signals essential for mechanotransduction pathways (Huang et al, 2004;O'Brien, 2011).…”
Section: Introductionmentioning
confidence: 99%
“…This new application of these materials contrasts with their historical use as matrices for reconstruction, for delivering cells and biological factors, or for controlled release. Although using biologically sourced scaffolds to deliver cells and factors remains an active area of research [105], as does the use of decellularized whole organs in regenerative medicine applications [106], such usage generally lies outside the focus of this review and will be deemphasized here. Rather, in this section we will emphasize the alternative strategy of using the scaffold to stimulate productive immune and inflammatory responses.…”
Section: High Complexity: Ecm-derived Scaffolds Inducing Therapeutmentioning
confidence: 99%